Multiple Functions of Lysyl Oxidase Like-2 in Oral Fibroproliferative Processes

Area of Science:

• Biochemistry
• Oral Biology
• Fibrosis Research

Background:

• Gingival overgrowth is a fibrotic side effect of medications like phenytoin.
• Lysyl oxidases (LOX) are crucial for collagen cross-linking and are upregulated in fibrosis.
• Lysyl oxidase-like 2 (LOXL2) is elevated in gingival overgrowth tissues.

Purpose of the Study:

• To investigate the specific roles of LOXL2 in promoting human gingival fibroblast proliferation and collagen accumulation.
• To explore the therapeutic potential of targeting LOXL2 in oral fibrotic conditions.

Main Methods:

• Utilized a novel LOXL2 isoform-selective inhibitor.
• Performed gene knockdown studies for loss-of-function analysis.
• Conducted gain-of-function studies.
• Assessed fibroblast proliferation and collagen accumulation in cultures.

Main Results:

• LOXL2 significantly stimulates gingival fibroblast proliferation, potentially via a platelet-derived growth factor B receptor-mediated pathway.
• LOXL2 enzyme activity promotes collagen accumulation.
• LOXL2 inhibition or gene knockdown effectively reduces collagen accumulation.

Conclusions:

• LOXL2 plays a key role in the pathogenesis of phenytoin-induced gingival overgrowth.
• Targeting LOXL2 presents a promising therapeutic avenue for managing oral fibrotic conditions.